Possible Adverse Fetal Effect of Insulin Lispro
- 2 October 1997
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (14), 1009-1010
- https://doi.org/10.1056/nejm199710023371414
Abstract
Insulin lispro is a new insulin analogue that acts more rapidly than regular insulin. To date, there are no reports on fetal outcomes after therapy with insulin lispro in pregnant women; indeed, pregnancy has been a contraindication for its use in all of the drug studies.1Keywords
This publication has 4 references indexed in Scilit:
- Insulin LisproNew England Journal of Medicine, 1997
- Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study GroupDiabetes, 1997
- Pre-Conception Care of Diabetes, Congenital Malformations, and Spontaneous AbortionsDiabetes Care, 1996
- A Reproductive and Developmental Toxicity Study in CD Rats of LY275585, [Lys(B28),Pro(B29)]-Human InsulinJournal of the American College of Toxicology, 1994